Antimalarial bioavailability and disposition of artesunate in acute falciparum, malaria

Antimicrobial Agents and Chemotherapy

Volumn 44, Issue 4, 2000, Pages 972-977

  Newton, Paul ^a,b   Suputtamongkol, Yupin ^c   Teja Isavadharm, Paktiya ^d   Pukrittayakamee, Sasithon ^a   Navaratnam, V ^e   Bates, Imelda ^f   White, Nicholas ^a,b  

^a MAHIDOL UNIVERSITY   (Thailand)

^b JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^c MAHIDOL UNIVERSITY   (Thailand)

^d ARMED FORCES RESEARCH INSTITUTE OF MEDICAL SCIENCES   (Thailand)

^e SCHOOL OF PHYSICS   (Malaysia)

^f LIVERPOOL SCHOOL OF TROPICAL MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARTESUNATE; CHLOROQUINE; CHLORPHENIRAMINE; CYANOCOBALAMIN; DIHYDROARTEMISININ; FERROUS SULFATE; FOLIC ACID; MEBENDAZOLE; MEFLOQUINE; METOCLOPRAMIDE; PARACETAMOL; PRIMAQUINE; PYRIDOXINE; QUININE; TETRACYCLINE; THIAMINE; TIABENDAZOLE;

ADULT; ANTIMALARIAL ACTIVITY; AREA UNDER THE CURVE; ARTICLE; BIOASSAY; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CONVALESCENCE; CROSSOVER PROCEDURE; DISTRIBUTION VOLUME; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG CLEARANCE; DRUG DISPOSITION; DRUG ELIMINATION; DRUG HALF LIFE; FEMALE; HUMAN; MALARIA FALCIPARUM; MALE; PLASMODIUM FALCIPARUM; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

ADMINISTRATION, ORAL; ADOLESCENT; ADULT; ANTIMALARIALS; AREA UNDER CURVE; ARTEMISININS; BIOLOGICAL AVAILABILITY; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; ELECTROCHEMISTRY; FEMALE; HALF-LIFE; HUMANS; INJECTIONS, INTRAVENOUS; INTESTINAL ABSORPTION; MALARIA, FALCIPARUM; MALE; MODELS, BIOLOGICAL; SESQUITERPENES;

EID: 0034065696     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.44.4.972-977.2000     Document Type: Article

References (27)

1. Ashton, M., T. N. Hai, N. D. Sy, D. X. Huong, N. V. Huong, N. T. Nieu and L. D. Cong. 1998. Artemisinin pharmacokinetics is time-dependent during repeated oral administration in healthy male adults. Drug Metab. Dispos. 26:25-27.
2. Barradell, L. B., and A. Fitton 1995. Artesunate: a review of its pharmacology and therapeutic efficacy in the treatment of malaria. Drugs 50:714-741.
3. Batty, K. T., L. T. A. Thu, K. F. Illett, T. X. Mai, N. C. Hung, N. P. Tien, S. M. Powell, H. V. Thien, T. Q. Binh, N. V. Kim, and T. M. E. Davis. 1998. A pharmacokinetic and pharmacodynamic study of artesunate in vivax malaria. Am. J. Trop. Med. Hyg. 59:823-827.
4. Batty, K. T., L. T. A. Thu, T. M. E. Davis, K. F. Illett, T. X. Mai, N. C. Hung, N. P. Tien, S. M. Powell, H. V. Thien, T. Q. Binh, and N. V. Kim. 1998. A pharmacokinetic and pharmacodynamic study of intravenous vs oral artesunate in uncomplicated falciparum malaria. Br. J. Clin. Pharmacol. 45:123-129.
5. Batty, K. T., K. F. Ilett, G. Edwards, S. M. Powell, J. L. Maggs, B. K. Park, and T. M. E. Davis. 1998. Assessment of the effect of malaria infection on hepatic microsomes of dihydroartemisinin using rat liver perfusions and microsomes. Br. J. Pharmacol. 125:159-167.
6. Bethell, D. B., P. Teja-Isavadharm, C. X. Phuong, P. T. Thuy, T. T. Mai, T. T. Thuy, N. T. Ha, P. T. Phuong, D. Kyle, N. P. J. Day, and N. J. White. 1997. Pharmacokinetics of oral artesunate in children with moderately severe Plasmodium falciparum malaria. Trans. R. Soc. Trop. Med. Hyg. 91:195-198.
7. Grace, J. M., D. J. Skanchy, and A. J. Aguilar. 1999. Metabolism of artelinic acid to dihydroqinghaosu by human liver cytochrome P450 3A. Xenobiotica 29:703-717.
8. Hien, T. T., and N. J. White. 1993. Qinghaosu. Lancet 341:603-608.
9. Khanh, N. X., P. J. de Vries, L. D. Ha, C. J. van Boxtel, R. Koopmans, and P. A. Kager. 1999. Declining concentrations of dihydroartemisinin in plasma during 5-day oral treatment with artesunate for falciparum malaria. Antimicroh. Agents Chemother. 43:690-692.
10. Maggs, J. L., S. Madden, L. P. Bishop, P. M. O'Neill, and B. K. Park. 1997. The rat biliary metabolites of dihydroartemisinin, an antimalarial endoperoxide. Drug Metab. Dispos. 25:1200-1204.
11. Meshnick S. R., T. E. Taylor, and S. Kamchonwongpaisan. 1996. Artemisinin and the antimalarial endoperoxides: from herbal remedy to targeted chemotherapy. Microbiol. Rev. 60:301-315.
12. Molyneux, M. E., S. Looareesuwan, I. S. Menzies, S. L. Grainger, R. E. Phillips, Y. Wattangoon, R. P. H. Thompson, and D. A. Warrell. 1989. Reduced hepatic blood flow and intestinal malabsorption in severe falciparum malaria. Am. J. Trop. Med. Hyg. 40:470-476.
13. Na-Bangchang, K., J. Karbwang, K. Congpoung, A. Thanavibul, and R. Ubalee. 1998. Pharmacokinetic and bioequivalence evaluation of two generic formulations of oral artesunate. Eur. J. Clin. Pharmacol. 53:375-376.
14. Navaratnam, V., M. N. Mordi, and S. M. Mansor. 1997. Simultaneous determination of artesunic acid and dihydroartemisinin in blood plasma by high-performance liquid chromatography for application in clinical pharmacological studies. J. Chromatogr. Ser. B Biomed. Sci. Appl. 692:157-162.
15. Nosten, F., C. Luxemburger, F. O. ter Kuile, C. Woodrow, J. Pa Eh, T. Chongsuphajaisiddhi, and N. J. White. 1994. Treatment of multidrug resistant falciparum malaria with a 3 day artesunate-mefloquine combination. J. Infect. Dis. 170:971-977.
16. Petras, J. M., D. E. Kyle, M. Gettayacamin, G. D. Young, R. A. Bauman, H. K. Webster, K. D. Corcoran, J. O. Peggins, M. A. Vane, and T. G. Brewer. 1997. Arteether: risks of two week administration in Macaca mulatta. Am. J. Trop. Med. Hyg. 56:390-396.
17. Pukrittayakamee, S., S. Looareesuwan, D. Keeratithakul, T. M. E. Davis, P. Teja Isavadharm, B. Nagachinta, A. Weber, A. Smith, D. Kyle, and N. J. White. 1997. A study of the factors affecting the metabolic clearance of quinine in malaria. Eur. J. Clin. Pharm. 52:487-493.
18. Silamut, K., P, Molunto, M. Ho, T. M. E. Davis, and N. J. White. 1991. Alpha 1-acid glycoprotein (orosomucoid) and plasma protein binding of quinine in falciparum malaria. Br. J. Clin. Pharmol. 32:311-315.
19. Silamut, K., R. Hough, T. Eggelte, S. Pukrittayakamee, B. Angus, and N. J. White. 1995. A simple method for assessing quinine pre-treatment in acute malaria. Trans. R. Soc. Trop. Med. Hyg. 89:665-667.
20. Teja-Isavadharm, P., F. Nosten, D. E. Kyle, C. Luxemberger, F. ter Kuile, J. O. Peggins, T. G. Brewer, and N. J. White. 1996. Comparative bioavailability of oral, rectal, and intramuscular artemether in healthy subjects - use of simultaneous measurement by high performance liquid chromatography with electrochemical detection and bioassay. Br. J. Clin. Pharmacol. 42:599-604.
21. White, N. J. 1992. Antimalarial pharmacokinetics and treatment regimens. Br. J. Clin. Pharmacol. 34:1-10.
22. White, N. J. 1994. Clinical pharmacokinetics and pharmacodynamics of artemisinin and its derivatives. Trans. R. Soc. Trop. Med. Hyg. 88(Suppl. 1):41-43.
23. White, N. J. 1996. Malaria, p. 1087-1164. In G. Cook (ed.), Manson's tropical diseases. W. B. Saunders Co., London, United Kingdom.
24. White, N. J. 1997. Assessment of the pharmacodynamic properties of antimalarial drugs in vivo. Antimicrob. Agents Chemother. 41:1413-1422.
25. White, N. J., M. van Vugt, and F. Ezzet. 1999. Clinical pharmacokinetics and pharmacodynamics of artemether - lumefantrine. Clin. Pharmacokinet. 37: 105-125.
26. World Health Organisation, Division of Control of Tropical Diseases. 1990. Severe and complicated malaria. Trans. R. Soc. Trop. Med. Hyg. 84(Suppl. 2):1-65.
27. Yang, S. D., J. M. Ma, J. H. Sub, D. X. Chen, and Z. Y. Song. 1986. Clinical pharmacokinetics of a new effective anti-malarial artesunate, a qinghaosu derivative. Chin. J. Clin. Pharmacol. 1:106-109.